Video: Disinformation and what businesses can do about it

A few weeks ago, when new proposals limiting J and F visa expansion were open for public comment, immigration quickly became a hot topic again at our research center, where more than half the scientists come from abroad. Some worried about their plan, others traded news and updates about the H1-B. A colleague asked if I was anxious too. To my own surprise, I wasn’t.

I used to be. But after weathering turbulent visa policies under different U.S. administrations, like many other international scholars, I have learned to stay flexible and mobile. My U.S. visa for a graduate program was delayed due to tensions between the U.S. and China several years ago. Up against a deadline for the program, I pivoted to Japan to continue the research training. What felt like a closed door became a new window: I fortunately joined a world-class team in tissue-engineering vascular medicine, broadened my view of clinical care and research, and began bridging my path as both practitioner and scientist. Committed to strengthening the “bench-to-bed” pipeline—learning real-world needs and translating research to meet them—I chose the United States again to carry this work forward.